Can autoantibody tests enhance lung cancer screening?—an evaluation of EarlyCDT(®)-Lung in context of the German Lung Cancer Screening Intervention Trial (LUSI)

BACKGROUND: Tumor-associated autoantibodies are considered promising markers for early lung cancer detection; so far, however, their capacity to detect cancer has been tested mostly in a clinical context, but not in population screening settings. This study evaluates the early detection accuracy, in...

Descripción completa

Detalles Bibliográficos
Autores principales: González Maldonado, Sandra, Johnson, Theron, Motsch, Erna, Delorme, Stefan, Kaaks, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867751/
https://www.ncbi.nlm.nih.gov/pubmed/33569307
http://dx.doi.org/10.21037/tlcr-20-727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867751/
https://www.ncbi.nlm.nih.gov/pubmed/33569307
http://dx.doi.org/10.21037/tlcr-20-727

Ejemplares similares